MICHAEL KWIAT: Open Payments
NPI 1366491094 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,679 in 187 payments from 16 companies in 2025. Trend: 2023 $56,102 · 2024 $63,399 · 2025 $66,679
Speaker / faculty: $44,674Travel & lodging: $11,359Consulting: $6,400Food & beverage: $4,237Education: $9
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 46 | $32,542 |
| Otsuka America Pharmaceutical, Inc. | 49 | $28,351 |
| E.R. Squibb & Sons, L.L.C. | 12 | $3,775 |
| ABBVIE INC. | 17 | $476 |
| Alkermes, Inc. | 9 | $264 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $246 |
| Axsome Therapeutics, Inc. | 14 | $244 |
| Janssen Pharmaceuticals, Inc | 3 | $221 |
| Lundbeck LLC | 7 | $154 |
| Sage Therapeutics, LLC | 7 | $140 |
Products named: INGREZZA, REXULTI, ABILIFY MAINTENA, COBENFY, VRAYLAR, CAPLYTA, Auvelity, SPRAVATO.
Industry payments across PA — which companies pay providers there.
